Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Christiane Filion Myklebust"'
Autor:
Xue Yan Cui, Geir Erland Tjønnfjord, Sandip M. Kanse, Anders Erik Astrup Dahm, Nina Iversen, Christiane Filion Myklebust, Ling Sun, Zhong Xing Jiang, Thor Ueland, James J. Campbell, Mitchell Ho, Per Morten Sandset
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract The infiltration of chronic lymphocytic leukemia (CLL) cells into lymphoid organs correlates with disease severity. CXCL12 is a key chemotactic factor for the trafficking of CLL. Tissue factor pathway inhibitor (TFPI) is a serine protease in
Externí odkaz:
https://doaj.org/article/ce0caf0c3fe64d058cc6da40b15f9c56
Autor:
Elisabeth Andersen, Maria Eugenia Chollet, Francesco Bernardi, Alessio Branchini, Marcello Baroni, Guglielmo Mariani, Alberto Dolce, Angelika Batorova, Ellen Skarpen, Christiane Filion Myklebust, Grethe Skretting, Per Morten Sandset
Publikováno v:
Applied Sciences, Vol 11, Iss 13, p 5762 (2021)
(1) Background: Congenital factor (F) VII deficiency is caused by mutations in the F7 gene. Patients with modest differences in FVII levels may display large differences in clinical severity. The variant p.A354V-p.P464Hfs is associated with reduced F
Externí odkaz:
https://doaj.org/article/b8e27bcd73384b93bc0f52a4b130b4e3
Autor:
Huda Omar Ali, Benedicte Stavik, Christiane Filion Myklebust, Elisabeth Andersen, Anders E A Dahm, Nina Iversen, Per Morten Sandset, Grethe Skretting
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0152114 (2016)
Oestrogens influence the pathology and development of hormone-sensitive breast cancers. Tissue factor pathway inhibitor (TFPI) has been shown to be associated with breast cancer pathogenesis. Recently, we found TFPI mRNA levels to be significantly re
Externí odkaz:
https://doaj.org/article/da25db980d864c6dbc7931d409b2db49
Autor:
Grethe Skretting, Mari Tinholt, Elisabeth Andersen, Benedicte Stavik, Nina Iversen, Christiane Filion Myklebust, Per Morten Sandset
Publikováno v:
Journal of Cellular Biochemistry. 120:12924-12936
Single nucleotide polymorphisms (SNPs) may play an important role in the risk of certain diseases. We have previously shown that the -287T/C SNP of the tissue factor pathway inhibitor (TFPI) gene promoter region exerts differential impact on TFPI mRN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60f2d333533144df951898ff4d8d8073
https://doi.org/10.1002/jcb.28563
https://doi.org/10.1002/jcb.28563
Autor:
Mitchell Ho, Geir E. Tjønnfjord, Ling Sun, Anders E.A. Dahm, Xue Yan Cui, Sandip M. Kanse, James Campbell, Nina Iversen, Zhongxing Jiang, Christiane Filion Myklebust, Per Morten Sandset, Thor Ueland
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
The infiltration of chronic lymphocytic leukemia (CLL) cells into lymphoid organs correlates with disease severity. CXCL12 is a key chemotactic factor for the trafficking of CLL. Tissue factor pathway inhibitor (TFPI) is a serine protease inhibitor a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb0af07513e3d66865f538f376490ed3
https://pubmed.ncbi.nlm.nih.gov/33664415
https://pubmed.ncbi.nlm.nih.gov/33664415
Autor:
Maria Eugenia Chollet, Elisabeth Andersen, Per Morten Sandset, Ellen Skarpen, Benedicte Stavik, Paul Hoff Backe, Christiane Filion Myklebust, Nina Iversen, Marit Sletten, Carola E. Henriksson, Heidi Glosli
Publikováno v:
Blood. 136:21-22
Introduction Congenital factor (F) VII deficiency is an inherited bleeding disorder with an autosomal recessive inheritance pattern. We report on two probands who had intracranial bleedings as toddlers. One of them had concomitant high titer FVII inh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d46f3551e7799f58a71f9d83e136bce8
https://doi.org/10.1182/blood-2020-139219
https://doi.org/10.1182/blood-2020-139219
Autor:
Christiane Filion Myklebust, Per Morten Sandset, Maria Eugenia Chollet, Gareth J. Sullivan, Ellen Skarpen, Javier Corral, María Eugenia de la Morena-Barrio, Marie-Christine Mowinckel, Carlos Bravo-Pérez, Bernd Thiede, Benedicte Stavik, Elisabeth Andersen
Publikováno v:
Blood. 136:4-4
Introduction To date studies on factor (F)VII and other hepatic vitamin K-dependent coagulation factors have relied on cell lines overexpressing these human genes. Even though these models have provided insight into the biology of these factors, they
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc1fad1988e712740babe50a5a9aa3bb
https://doi.org/10.1182/blood-2020-139211
https://doi.org/10.1182/blood-2020-139211
Autor:
Elisabeth Andersen, Maria Eugenia Chollet, Grethe Skretting, Per Morten Sandset, Ampaiwan Chuansumrit, Christiane Filion Myklebust, Francesco Bernardi, Mirko Pinotti, Ellen Skarpen
Publikováno v:
Thrombosis and haemostasis. 118(4)
Congenital factor (F) VII deficiency is a bleeding disorder caused by a heterogeneous pattern of mutations in the F7 gene. Protein misfolding due to mutations is a strong candidate mechanism to produce the highly represented type I FVII deficiency fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ecf664ae18d0b55594d8a0b9d9388d0
https://pubmed.ncbi.nlm.nih.gov/29618153
https://pubmed.ncbi.nlm.nih.gov/29618153
Autor:
Jens Preben Morth, Ampaiwan Chuansumrit, Elisabeth Andersen, Maria Eugenia Chollet, Grethe Skretting, Francesco Bernardi, Mirko Pinotti, Christian J. Koehler, Ellen Skarpen, Christiane Filion Myklebust, Per Morten Sandset, Bernd Thiede
Activated factor (F) VII is a vitamin K-dependent glycoprotein that initiates blood coagulation upon interaction with tissue factor. FVII deficiency is the most common of the rare congenital bleeding disorders. While the mutational pattern has been e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::059b6de0e90c42c585de1873fa7ffe7e
http://hdl.handle.net/11392/2396367
http://hdl.handle.net/11392/2396367
Autor:
Christiane Filion Myklebust, Huda Omar Ali, Per Morten Sandset, Grethe Skretting, Nina Iversen, Benedicte Stavik, Marianne S. Andresen
Publikováno v:
Molecular and cellular endocrinology. 443
Hormone-sensitive cancers can be influenced by estrogens, a process usually mediated through the estrogen receptor (ER). Tissue factor pathway inhibitor type 2 (TFPI-2) is a Kunitz-type serine protease inhibitor involved in regulating the extracellul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7dabbae6fe5843a6df7fba885efd1b0
https://pubmed.ncbi.nlm.nih.gov/28088469
https://pubmed.ncbi.nlm.nih.gov/28088469